Studied in trials
Studied regimens (not recommendations)
Studied in trials — not a recommended dose
- No controlled human studies of the heptapeptide have been published. Dosing protocols promoted in unregulated markets are unsubstantiated.
Dose evidence detail — TB-500
Detailed dose evidence documented for TB-500 in its monograph — reference only, not dosing recommendations.
Reference only — not a dosing recommendation.
Not established
No approved labeled regimen
No established or recommended human dose.
- None. Neither the heptapeptide nor full-length Tβ4 is approved for any indication.
Not established
What is not established
- No established or recommended human dose.